Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sidecar Health, which offers health insurance billed through a debit card, attracted Comcast Ventures to a round that brought its funding total to $40m.

Increasing both the number of shares and share price, iTeos Therapeutics has raised more than $201m in an offering that provided an exit to UCL and Ludwig Institute.

Nurix Therapeutics, a Celgene-backed cancer treatment developer based on UC Berkeley and San Francisco research, priced shares above its range to raise $209m.

Forge is working on a gene therapy treatment invented at UPMC but has covered its bases by targeting viral vector production for third-party clients.

Nurix Therapeutics, a Celgene-backed cancer treatment developer based on UC Berkeley and San Francisco research, priced shares above its range to raise $209m.

Increasing both the number of shares and share price, iTeos Therapeutics has raised more than $201m in an offering that provided an exit to 6 Dimensions Capital.

The cloud-based design platform has raised $100m from new and existing shareholders, but it is unclear if CNF Investments was among those that returned.

Earlier reports suggested Geltor was seeking as much as $100m, but the Archer Daniels Midland and Wilbur-Ellis-backed company has now seemingly secured $90m.

FreightWaves has secured $37m across two rounds from investors including Kayne Partners Fund to bring the Hearst and Prologis-backed company’s total funding to more than $75m.